Although the treatment of myocardial infarction (MI) has improved considerably, it is still a
worldwide disease with high morbidity and high mortality. Whilst there is still a long way to …

As the most abundant and conserved internal modification in eukaryote RNAs, N6-
methyladenosine (m6A) is involved in a wide range of physiological and pathological …

RNA m6A modification is the most widely distributed RNA methylation and is closely related
to various pathophysiological processes. Although the benefit of regular exercise on the …

Background AlkB homolog 5 (ALKBH5) is a N6-methyladenosine (m6A) demethylase
associated with the development, growth, and progression of multiple cancer types …

Abstract Background N6-methyladenosine (m6A) is the most common post-transcriptional
modification at the RNA level. However, the exact molecular mechanisms of m6A epigenetic …

Background Previous studies have confirmed that the bacterium Treponema pallidum (TP)
or its proteins provide signals to macrophages that induce an inflammatory response; …

YTHDF1 is the most versatile and powerful reader protein of N 6-methyladenosine (m6A)-
modified RNA, and it can recognize both G (m6A) C and A (m6A) C RNAs as ligands without …

Background METTL3 is the core catalytic enzyme in m6A and is involved in a variety of
cardiovascular diseases. However, whether and how METTL3 plays a role during …

Endotoxemia triggers life-threatening immune and cardiovascular response that leads to
tissue damage, multi-organ failure, and death. The understanding of underlying molecular …

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide.
Recent studies have shown that n6-methyladenosine (m6A) plays a major role in …